“Trump’s pharmaceutical policies have too many uncertain aspects and will not bring immediate impacts”
President-elect Donald Trump’s policies may bring positive impacts on Korean biosimilars’ entry to overseas markets, but an anticipation was made that it will not significantly influence the pharmaceutical market, yet.
At the ‘Political and Legislative Countermeasures for Biotechnology and Pharm...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
